Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer.
Funding:@CRUKresearch
Our new paper in @BJGPjournal: we model different patterns of proposed medical hormonal therapy (HRT) usage for well women age 50 who have different patterns of breast cancer family history.
https://t.co/5Lf84oVBCv
https://t.co/tXeKAaCMe8
https://t.co/rRm7555Ml4 (1/n)
What might it be like to navigate a genetic diagnosis and share it with family members? @rach_horton and @gabriellesamue1 talk to Julie Young from the @CanGeneCanVar patient reference panel about her experience.
Listen on Spotfiy: https://t.co/9gfzjXtOJM
#GenomicsConversation
Congratulations @Isaac__Allen, PhD student in @antonis02 group, on this paper in @lancetRH_Europe on risks of second cancers in female and male #BreastCancer survivors, using NHS England data on ~600,000 patients in England. https://t.co/Z97vln3PJ9
@CRUKresearch
1/ Pleased to share a new, population-scale Second Cancer Risks analysis in male and female #BreastCancer survivors, using NHS England data, through my PhD work. https://t.co/qlKpOLzzal
Check out the latest blog post on CanGene-CanVar which is a publication spotlight from Work Package 4: https://t.co/IaR0BgmuKc
Well done to everyone involved!
Check out this podcast from @GenomicsEngland in collaboration with @RochelleLGold ,@kohut_kelly and @Helen_Hanson1 discussing how genetic tests are transforming cancer prevention: https://t.co/7cRs1l8wSl
Check out our latest blog post featuring a publication spotlight on Work Package 5's most recent publication! Well done to all. https://t.co/DbhySythz6
We are currently looking for a clinician to undertake a 3-year clinic PhD fellowship related to validation of new functional assay data for cancer susceptibility genes. the deadline to apply is 10/12/23. Find out more here: https://t.co/8xaPApFNVU @ICR_London
Our latest blog post is written by Charlene Young who, along with @kohut_kelly, co-lead a very important short filming project on lived experiences with cancer. Check out Charlene's perspective of the experience here: https://t.co/wtLbNvPNwx
Fantastic news 👏 a testament to the hard work and time everyone has put in to deliver co-deliver this project - and excellently coordinated by you @kohut_kelly and the team at UoS
Celebrating all the patients, researchers and other stakeholders who have partnered with us to co-design the patient website Lynch Choices to support decisions about managing genetic cancer risk.
Thank you Innovate Awards for recognising excellence in health and care innovation
#ipos2023 partnered with Dr Sayyed in Pakistan to explore barriers & facilitators to bowel screening and presenting earlier with cancer symptoms for cultural translation of patient decision aid
Thanks @CanGeneCanVar@unisouthampton
More when @RazaSayyed12 presents at @EHTGtweets
Check out our latst blog post featuring a publication spotlight on Work Package 5's most recent publication! Well done to all involved. #CGCV
https://t.co/v9ASEQG8Oh
Our WP2 team had an amazing time at #CCG2023 conference in Cambridgeshire this week, coming away with a winning poster! Well done to @CRowlandsBio, @DrAliceGarrett, Sophie Allen and the entire team 👏
Read the most recent publication from our Work Package 1 team: Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis https://t.co/0NuOKzBZ20
Listen Here: Dr. Rachel Horton and Dr. Gabrielle Samuel speak with PRP member Julie Young about navigating her diagnosis with the genetic disorder Lynch syndrome and sharing this with her family members. https://t.co/SGSo4c2jId #CMP
Check out our Patient Reference Panel member Julie Young’s blogpost about her recent ethics placement at the Ethox Centre as part of the CanGene-CanVar programme: https://t.co/NqQpxhk3w7 #CMP